
Glenmark receives FDA approval for Hydrochloride Ophthalmic Solution
New Jersey: Indian drug maker Glenmark Pharmaceuticals, US arm has received final approval by the United States Food & Drug Administration (U.S. FDA) for Olopatadine Hydrochloride Ophthalmic Solution. Making the announcement in a stock exchange filing …